This publication shows how our « free of hypothesis » approach can describe all the effects which are induced by an ingredient on an ex vivo classic model. It gives for the ingredient a more extensive understanding of the mechanisms of action and some specific insights, which were also predictive as confirmed at the clinical level, and which allowed supporting a complete and original claiming.

This method shows huge advantages :

– It is based on proteins which are in charge of the structure and the metabolic functions in the cells,

– It is untargeted, which allows to have at the same time a complete view on positive and possible toxic effects.

Link to our JOCD publication

Pubmed https://www.ncbi.nlm.nih.gov/pubmed/29797450

 

      62, Route Nationale 113

30620 BERNIS

Tel : +33 4 66 04 77 99
Fax : +33 4 66 04 77 97

e-mail :   gskorski@phylogene.com
web :      www.phylogene.com

http://ms.phylogene.com

LinkedIn : https://www.linkedin.com/company/phylogene

Twitter :    https://twitter.com/Phylogene_One

Recent Posts

Skinobs at the 2024 ISBS Congress, 4-6 June 2024

  Skinobs is thrilled to announce our presence during the 2024 ISBS Congress, in New…

Skin Deep: The Potential of Microbiome Cosmetics via Springer

The interplay between the skin microbiome and its host is a complex facet of dermatological…

Chinese researchers Identify IGF2 in Oral Mucosa as Key Factor for ‘Scarless Wound Healing via Cosmetics Design Asia

A group of researchers from China have identified Insulin-like Growth Factor 2 (IGF2) in oral…